Pharmacology of a Potent and Novel Inhibitor of the NOD-like receptor pyrin domain-containing protein 3 (NLRP3) Inflammasome that Attenuates Development of NASH and Liver Fibrosis
暂无分享,去创建一个
J. Veal | A. Feldstein | Christopher Mcbride | H. Hoffman | Rama F. Pranadinata | Matthew D Mcgeough | D. Povero | R. Stansfield | A. Santini | Casey D. Johnson | G. Ambrus-Aikelin | Jeffrey | Milos Lazic | A. Stafford